Dose-dense induction with sequential high-dose cytarabine and mitoxantone (S-HAM) and pegfilgrastim results in a high efficacy and a short duration of critical neutropenia in de novo acute myeloid leukemia: a pilot study of the AMLCG. (Q46170697)
Jump to navigation
Jump to search
scientific article published on 8 January 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dose-dense induction with sequential high-dose cytarabine and mitoxantone (S-HAM) and pegfilgrastim results in a high efficacy and a short duration of critical neutropenia in de novo acute myeloid leukemia: a pilot study of the AMLCG. |
scientific article published on 8 January 2009 |
Statements
1 reference
Dose-dense induction with sequential high-dose cytarabine and mitoxantone (S-HAM) and pegfilgrastim results in a high efficacy and a short duration of critical neutropenia in de novo acute myeloid leukemia: a pilot study of the AMLCG. (English)
1 reference
1 reference
1 reference
Michael Unterhalt
1 reference
Jan Braess
1 reference
Karsten Spiekermann
1 reference
Peter Staib
1 reference
Andreas Grüneisen
1 reference
Bernhard Wörmann
1 reference
Wolf-Dieter Ludwig
1 reference
Albrecht Reichle
1 reference
Rudolf Peceny
1 reference
Daniel Oruzio
1 reference
Christoph Schmid
1 reference
Xaver Schiel
1 reference
Marcus Hentrich
1 reference
Christina Sauerland
1 reference
Michael Fiegl
1 reference
Wolfgang Kern
1 reference
Christian Buske
1 reference
Achim Heinecke
1 reference
Herrad Baurmann
1 reference
Dietrich W Beelen
1 reference
Wolfgang E Berdel
1 reference
Thomas Büchner
1 reference
Wolfgang Hiddemann
1 reference
8 January 2009
1 reference
1 reference
113
1 reference
17
1 reference
3903-3910
1 reference
Identifiers
1 reference